Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands.
Progesterone-binding proteins from human, rabbit, sheep and guinea pig myometrial cytosol, all induced with oestradiol, as well as from pregnant guinea pig myometrium and plasma were investigated. The physico-chemical properties of the oestradiol-induced binding proteins were very similar in all the species studied. In all, 63 steroids were tested for their ability to compete with tritiated progesterone for the binding sites on these six proteins and their relative affinities were determined. The studies reveal that the ligand specificities of oestrogen-induced myometrial binding proteins from human, rabbit and sheep are rather similar, whereas that from guinea pig myometrium has different binding characteristics. The properties of the binding proteins from pregnant guinea pig uterus and plasma differ substantially from all of the induced proteins. It is clear from the different physico-chemical characteristics and binding specificities that the oestrogen-induced myometrial protein of the guinea pig is not the same as that which appears in the myometrium and plasma during pregnancy. The binding energies of the well bound progestational compounds were of the order of -12 Kcal/mole, half of which stems from the interaction of the steroid nucleus with the protein. The specific interaction of the protein with the two functional groups, the 3-keto-4-ene system and the acetyl sid chain each contributed-3 Kcal/mole. In the case of the rabbit, sheep and human proteins a 17alpha-ethynyl-17beta-hydroxyl function could replace the acetyl side chain. For a large number of steroids reasonable agreement existed between the degree of binding to the rabbit myometrial protein and in vivo biological activity (Clauberg-McPhail test) in the same species. The data suggest that as far asthe binding aspect is concerned, the rabbit is an appropriate model for assessing the biological activity of compounds under development for human application. The in vitro binding system is also a useful tool to assess whether steroids need to be bio-activated before eliciting a biological response.
D000368:Aged; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D001665:Binding Sites; D001667:Binding, Competitive; D001798:Blood Proteins / Q000378:metabolism*; D002499:Centrifugation, Density Gradient; D002606:Charcoal; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D004970:Estrone / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008024:Ligands; D008593:Menopause; D008954:Models, Biological; D011247:Pregnancy; D011270:Pregnancy, Animal; D011278:Pregnanes / Q000378:metabolism*; D011374:Progesterone / Q000378:metabolism*; D011372:Progestins / Q000378:metabolism*; D011485:Protein Binding; D011817:Rabbits; D011956:Receptors, Cell Surface; D012756:Sheep; D013045:Species Specificity; D014599:Uterus / Q000378:metabolism*
D001565:Benzoates; D001798:Blood Proteins; D008024:Ligands; D011278:Pregnanes; D011372:Progestins; D011956:Receptors, Cell Surface; D002606:Charcoal; D004970:Estrone; D011374:Progesterone; D004958:Estradiol